Table A1.

Supl. Clinical characteristic of the study group.

Parameter	Study Group n = 59 (100%)	FA n = 16 (100%)	ADFA n = 38 (100%)	AD n = 5 (100%)
Clinical symptoms, n (%)
skin
rush, erythema, xerosis	46 (77.96)	3 (18.75)	38 (100)	5 (100)
itching	0	0	17 (44.73)	2 (40)
urticarial/angiooedema	5 (8.47)	1 (6.25)	4 (10.25)	0
gastrointestinal
colic/abdominal pain	43 (72.88)	12 (75)	29 (76.31)	2 (40)
vomiting/massive regurgitation	26 (44.06)	6 (37.5)	19 (50)	1 (20)
weight loss/poor weight gain	9 (15.25)	0	9 (23.68)	0
loose of apetite /flatulence/reflection	6 (10.16)	2 (12.5)	4 (10.52)	0
diarrhea	24 (40.60)	8 (50)	16 (42.10)	0
blood/mucus in stool	23 (38.98)	9 (56.25)	13 (34.21)	1 (20)
constipation	2 (3.38)	1 (6.25)	0	1 (20)
others
runny nose/snuffles	9 (15.25)	5 (31.25)	4 (10.52)	0
wheezing	4 (6.77)	1 (6.25)	3 (7.89)	0
recurrent cough	2 (3.38)	1 (6.25)	1 (2.63)	0
pallor/cyanosis after ingestion	6 (10.16)	3 (18.75)	3 (7.89)	0
sweating, weakness after eating food	3 (5.08)	2 (12.5)	1 (2.63)	0
sIgE, n (%)
at least >1	10 (16.94)	2 (12.5)	8 (21.05)	0
cow’s milk	0	2 (12.5)	6 (15.78)	0
egg	0	0	1 (2.63)	0
wheat	0	0	1 (2.63)	0
peanut	0	0	1 (2.63)	0
SCORAD index, points
mean ± SD	23.77 ± 19	-	23.03 ± 17.4	29.4 ± 20.8
Atopic dermatitis severity, n (%)
Mild <20 pkt	22 (37.28)	0	20 (52.63)	2 (40)
Moderate 20–40 pkt	14 (23.72)	0	13 (34.21)	1 (20)
Severe >40 pkt	7 (11.86)	0	5 (13.15)	2 (40)
AD onset (<12 weeks), n (%)	35 (59.32)	-	31 (81.57)	4 (80)
mean ± SD	6.4 ± 5.4	-	6.3 ± 5.3	6.6 ± 5.5
Types of CMA from gastrointestinal tract
FPIP	19 (32.20)	8 (50)	11 (28.94)	0
FPIES	6 (10.16)	2 (12.5)	4 (10.52)	0
FGIDs	21 (35.59)	5 (31.25)	16 (42.10)	0
IgE-mediated FA	8 (13.56)	2 (12.5)	6 (15.78)	0